Do you want to read an article? Please log in or register.
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
Migraine and Headache
RECOMMENDED
Related content
Migraine and Headache
Calcitonin Gene-Related Peptide Modulators - The History and Renaissance of a New Migraine Drug Class
Headache.
Hargreaves R, Olesen J
doi: 10.1111/head.13510.
Migraine and Headache
Interictal levels of calcitonin gene related peptide in gingival crevicular fluid of chronic migraine patients
Neurol Sci.
Fekrazad R, Sardarian A, Azma K, Karami M, Borhani-Haghighi A, Gharesi-Fard B, Movahedi B
doi: 10.1007/s10072-018-3340-3.
Migraine and Headache
Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine
Headache
Popoff E, Johnston K, Croop R, Thiry A, Harris L, Powell L, Coric V, L'Italien G, Moren J
doi: 10.1111/head.14128
Migraine and Headache
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions
Cephalalgia.
Ashina M, Kudrow D, Reuter U, Dolezil D, Silberstein S, Tepper SJ, Xue F, Picard H, Zhang F, Wang A, Zhou Y, Hong F, Klatt J, Mikol DD
doi: 10.1177/0333102419888222.
RECOMMENDED
Migraine and Headache
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
Lancet.
Croop R, Goadsby PJ, Stock DA, Conway CM, Forshaw M, Stock EG, Coric V, Lipton RB
doi: 10.1016/S0140-
Migraine and Headache
Effect of Infusion of Calcitonin Gene-Related Peptide on Cluster Headache Attacks: A Randomized Clinical Trial
JAMA Neurol.
Vollesen ALH, Snoer A, Beske RP, Guo S, Hoffmann J, Jensen RH, Ashina M
doi: 10.1001/jamaneurol.
Migraine and Headache
Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study
Headache
Kawata AK, Shah N, Poon JL, Shaffer S, Sapra S, Wilcox TK, Shah S, Tepper SJ, Dodick DW, Lipton RB
doi: 10.1111/head.14053
COMMENTED
Migraine and Headache
Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab
Cephalalgia.
Buse DC, Lipton RB, Hallström Y, Reuter U, Tepper SJ, Zhang F, Sapra S, Picard H, Mikol DD, Lenz RA
doi: 10.1177/0333102418789072.
RECOMMENDED
Migraine and Headache
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine: The ACHIEVE II Randomized Clinical Trial
★ 2
Recommended by
Prof. Dr Christian Kamm, Faculty Member
JAMA.
Lipton RB, Dodick DW, Ailani J, Lu K, Finnegan M, Szegedi A, Trugman JM
doi: 10.1001/jama.2019.16711.